340 related articles for article (PubMed ID: 26746801)
1. Hot melt extrusion based solid solution approach: Exploring polymer comparison, physicochemical characterization and in-vivo evaluation.
Fule R; Paithankar V; Amin P
Int J Pharm; 2016 Feb; 499(1-2):280-294. PubMed ID: 26746801
[TBL] [Abstract][Full Text] [Related]
2. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
[TBL] [Abstract][Full Text] [Related]
3. A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products.
Kelleher JF; Gilvary GC; Madi AM; Jones DS; Li S; Tian Y; Almajaan A; Senta-Loys Z; Andrews GP; Healy AM
Int J Pharm; 2018 Jul; 545(1-2):183-196. PubMed ID: 29730176
[TBL] [Abstract][Full Text] [Related]
4. Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.
Agrawal AM; Dudhedia MS; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):133-47. PubMed ID: 26729533
[TBL] [Abstract][Full Text] [Related]
5. Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies.
McFall H; Sarabu S; Shankar V; Bandari S; Murthy SN; Kolter K; Langley N; Kim DW; Repka MA
Int J Pharm; 2019 Jan; 554():302-311. PubMed ID: 30395959
[TBL] [Abstract][Full Text] [Related]
6. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
7. Application of hot melt extrusion for improving bioavailability of artemisinin a thermolabile drug.
Kulkarni C; Kelly AL; Gough T; Jadhav V; Singh KK; Paradkar A
Drug Dev Ind Pharm; 2018 Feb; 44(2):206-214. PubMed ID: 29145748
[TBL] [Abstract][Full Text] [Related]
8. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers.
Maniruzzaman M; Rana MM; Boateng JS; Mitchell JC; Douroumis D
Drug Dev Ind Pharm; 2013 Feb; 39(2):218-27. PubMed ID: 22452601
[TBL] [Abstract][Full Text] [Related]
9. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
10. Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion.
Zhang Y; Luo R; Chen Y; Ke X; Hu D; Han M
AAPS PharmSciTech; 2014 Jun; 15(3):560-8. PubMed ID: 24570374
[TBL] [Abstract][Full Text] [Related]
11. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
12. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
13. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
[TBL] [Abstract][Full Text] [Related]
14. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
15. Analyzing the impact of different excipients on drug release behavior in hot-melt extrusion formulations using FTIR spectroscopic imaging.
Pudlas M; Kyeremateng SO; Williams LAM; Kimber JA; van Lishaut H; Kazarian SG; Woehrle GH
Eur J Pharm Sci; 2015 Jan; 67():21-31. PubMed ID: 25445833
[TBL] [Abstract][Full Text] [Related]
16. Indomethacin-Kollidon VA64 Extrudates: A Mechanistic Study of pH-Dependent Controlled Release.
Tres F; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
Mol Pharm; 2016 Mar; 13(3):1166-75. PubMed ID: 26845251
[TBL] [Abstract][Full Text] [Related]
17. In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a Meloxicam-Copovidone Amorphous Solid Dispersion.
Haser A; Cao T; Lubach JW; Zhang F
Mol Pharm; 2018 Mar; 15(3):1226-1237. PubMed ID: 29412681
[TBL] [Abstract][Full Text] [Related]
18. Development and optimization of ketoconazole oral strips by means of continuous hot-melt extrusion processing.
Maniruzzaman M; Farias S; Slipper IJ; Boateng JS; Chowdhry BZ; Nair A; Douroumis D
J Pharm Pharmacol; 2016 Jul; 68(7):890-900. PubMed ID: 27164996
[TBL] [Abstract][Full Text] [Related]
19. Implementation of transmission NIR as a PAT tool for monitoring drug transformation during HME processing.
Islam MT; Scoutaris N; Maniruzzaman M; Moradiya HG; Halsey SA; Bradley MS; Chowdhry BZ; Snowden MJ; Douroumis D
Eur J Pharm Biopharm; 2015 Oct; 96():106-16. PubMed ID: 26209124
[TBL] [Abstract][Full Text] [Related]
20. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
